Bathi operasional sadurunge amortisasi: mainzbiomed.com (MYNZ)

Logo perusahaan publik Mainz Biomed N.V. (MYNZ)

Consistent demand for colorectal cancer screening via ColoAlert systems provides Mainz Biomed N.V. (MYNZ) with a steady cash flow. The absolute EBITDA level demonstrates current operating profit dynamics, where the value of 0.00 reflects this status. Business efficiency is based on the automation of biomarker tests and growing physician confidence across Europe and the US.

MYNZ mainzbiomed.com: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 11.03.2026

Ringkesan rincian data analitis Mainz Biomed N.V. (MYNZ)

- rega pasar lan target rega analis:
Rega saham Mainz Biomed NV|MYNZ - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Mainz Biomed|MYNZ - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Mainz Biomed|MYNZ - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku mainzbiomed.com|MYNZ - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Mainz Biomed N.V.|MYNZ - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal mainzbiomed.com|MYNZ - Gunggung utang perusahaan|Utang-utang marang aset resik Mainz Biomed|MYNZ - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Mainz Biomed|Indikator likuiditas cepet mainzbiomed.com
- data bathi bisnis lan rasio investasi:
MYNZ - Bathi resik|Proyeksi bathi mangsa ngarep Mainz Biomed N.V.|MYNZ - Pangali P/E|Kapitalisasi marang proyeksi bathi Mainz Biomed NV|MYNZ - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Mainz Biomed|MYNZ - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Mainz Biomed|MYNZ - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan mainzbiomed.com|MYNZ - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Mainz Biomed N.V.
Ringkesan analitik perusahaan:MYNZ Mainz Biomed NV
Produk asil prodhuksi Mainz Biomed N.V.

This indicator reflects the actual liquidity inflow from the core operations of Mainz Biomed N.V. (MYNZ), eliminating the temporary gaps of standard reporting through daily cash flow monitoring. By analyzing quarterly EBITDA, investors can see how the supply of diagnostic tests to clinics in the US and Europe converts into actual capital, allowing for an objective assessment of the business's resilience to market downturns.

Pesaing Mainz Biomed N.V. (MYNZ)

Bathi operasional EBITDA Caris Corp CAI|GH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|VCYT (veracyte.com) - Bathi operasional sadurunge amortisasi|CELC: Bathi operasional EBITDA|GRAIL Inc (GRAL) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Myriad Genetics Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CSTL|Bathi operasional sadurunge ngurangi amortisasi BNR (Burning Rock Biotech)|VNRX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Biodesix BDSX|Pendapatan operasional sadurunge ngurangi amortisasi Precipio Inc. (PRPO)|Check-Cap Medical - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi OncoCyte Inc OCX